The BLGO chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the BLGO chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The BLGO stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View BLGO Detailed Price Forecast - CNN Money||View BLGO Detailed Summary - Google Finance|
|View BLGO Detailed Summary - Yahoo! Finance||View BLGO Stock Research & Analysis - Zacks.com|
|View BLGO Trends & Analysis - Trade-Ideas||View BLGO Major Holders - Barrons|
|View BLGO Call Transcripts - NASDAQ||View BLGO Breaking News & Analysis - Seeking Alpha|
|View BLGO Annual Report - CompanySpotlight.com||View BLGO OTC Short Report - OTCShortReport.com|
|View BLGO Fundamentals - TradeKing||View BLGO SEC Filings - Bar Chart|
|View Historical Prices for BLGO - The WSJ||View Performance/Total Return for BLGO - Morningstar|
|View the Analyst Estimates for BLGO - MarketWatch||View the Earnings History for BLGO - CNBC|
|View the BLGO Earnings - StockMarketWatch||View BLGO Buy or Sell Recommendations - MacroAxis|
|View the BLGO Bullish Patterns - American Bulls||View BLGO Short Pain Metrics - ShortPainBot.com|
|View BLGO Stock Mentions - StockTwits||View BLGO Stock Mentions - PennyStockTweets|
|View BLGO Stock Mentions - Twitter||View BLGO Investment Forum News - Investor Hub|
|View BLGO Stock Mentions - Yahoo! Message Board||View BLGO Stock Mentions - Seeking Alpha|
|View Insider Transactions for BLGO - SECform4.com||View Insider Transactions for BLGO - Insider Cow|
|View BLGO Major Holdings Summary - CNBC||View Insider Disclosure for BLGO - OTC Markets|
|View Insider Transactions for BLGO - Yahoo! Finance||View Institutional Holdings for BLGO - NASDAQ|
|View BLGO Stock Insight & Charts - FinViz.com||View BLGO Investment Charts - StockCharts.com|
|View BLGO Stock Overview & Charts - BarChart||View BLGO User Generated Charts - Trading View|
Dennis Calvert, CEO of BioLargo, Inc. (BLGO) (BioLargo, BLGO, the “Company”) recently spoke with “Stock Day” host Everett Jolly about the company’s commercial progress. BioLargo, Inc. is a dynamic technology incubator and environmental engineering company that develops innovative technology solutions for industry with a focus on clean air, clean water and advanced wound care.
BioLargo, Inc. to Present at the 8th Annual LD Micro Invitational
Posted on Friday June 01, 2018
LOS ANGELES, CA / ACCESSWIRE / June 1, 2018 / BioLargo, Inc. (OTCQB: BLGO), an innovator of sustainable science and technology and full-service environmental engineering company today announced that it ...
BioLargo Achieves Record Product Sales and Revenues in Q1 2018
Posted on Wednesday May 16, 2018
BioLargo, Inc. (BLGO), an innovator of sustainable science and technology and full-service environmental engineering company, announced that on May 14, 2018, it had filed its 10-Q quarterly report. While we remain confident that we will ultimately receive premarket clearance for our products, we can make no assurance or prediction as to success of Clyra’s efforts, and must wait patiently for the process with the FDA to conclude.
BioLargo reduces balance sheet liabilities by more than $5,400,000
Posted on Wednesday May 09, 2018
BioLargo, Inc. (BLGO), an innovator of sustainable science and technology and full-service environmental engineering company, announced that on May 7, 2018, it had reduced the liabilities on its balance sheet by $4,133,378, through the conversion of promissory notes into 15,747,482 shares of common stock. The notes converted had maturity dates ranging from June 1, 2018, through June 20, 2020, and had been issued to investors in the Company’s prior “unit” offerings. BioLargo also reported that it will convert an additional $1,314,380 of debt to equity on June 1, 2018, resulting in the issuance of 3,211,004 shares of common stock (plus shares for accrued interest) for a total reduction of $5,447,758 of debt to equity.